Targeted Delivery

A year in Longevity: different perspectives

Looking for anti-aging solutions in some unusual places. 2020 has seen Longevity.Technology covering a variety of news in the Longevity sector, from discoveries in the...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

Nanotech ‘passport to the brain’ for therapeutics

Researchers discover a new nanotech approach to deliver therapies through the blood-brain barrier. Scientists at Tufts University have discovered a way to deliver therapeutics safely...

Nanoparticles target immune response using red blood cells

Polystyrene nanoparticles deliver drug payload directly to the spleen and bypass lengthy clinical trial requirements. Vaccines are making headlines at the moment, for obvious reasons, ...

When scaling down is as vital as scaling up

Robotics continue to scale down - but can researchers include the autonomy necessary for the medical intervention that will prolong life? Tiny robots could be...

NaNotics raising Series B to support Asia-Pacific trials

NaNotics nano particles could revolutionise of a host of chronic and acute conditions. Louis Hawthorne, CEO of NaNotics, has released an 11 minute video aimed...

Hydrogel scaffold raises hopes for tissue regeneration

Wyss Institute hydrogel therapy can repair nerves, muscles and blood vessels. Naturally-occurring molecules VEGF and IGF-1 can enhance tissue regrowth and repair, but getting them...

‘Internet of the body’ device to regulate genes externally

Bioelectric remote control of cell signalling drives synthetic biology progress: tests trigger bioengineered cells to release insulin. A team at the Department of Biosystems Science and...

Novel approach breaks through blood-brain barrier

Molecular transport is on target for shuttling therapies directly into the brain. Like an exclusive nightclub, the brain has the best bouncer in the business....

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

‘Damage-eating’ protein fixes DNA harmed by aging

A toolkit of proteins that can repair breaks in strands of DNA has been discovered by scientists at the Universities of Sheffield and Oxford. DNA...

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” - seeking investment to evolve world’s smallest syringe...

Plaque eating nanoparticle prevents heart attacks

Studies suggest a new Trojan horse nanoparticle can eat-up artery-narrowing plaque – a common cause of heart attacks. Scientists at Michigan State University have invented...

Precious nano metals hold key to new treatments

Metallic nanotechnology may turn out to be the most precious way to utilise metals, at least when it comes to increasing healthspan and lifespan. When...

Super-human blood for targeted delivery

Physicists hope their new 'super-human' red blood cells will be able to deliver drugs to specific targets within the body. A team of physicians at...

Nanotechnology – good things in small packages

With more than 60 FDA-approved drugs containing nanomaterials , not to mention nanotech that builds and repairs, it’s time to take a deeper-dive into...

AI-built “living machine” is world first

Evolved by AI algorithms from frog cells into something not remotely Kermit-like, this living machine is a real leap forward for Longevity. Forget everything you...

Chip delivers Alzheimer’s protein direct to brain

The blood-brain barrier (BBB) can be notoriously difficult to overcome; an Israeli team have overcome this with a nanochip that carries a neurodegenerative-combatting "neural growth...

Exclusive interview: A new generation of senolytic

When is a drug not a drug? When it's a NaNot. Interesting new technology that's already on its way through FDA and targeting $40m Series...

NaNotics promises a new kind of medication

In another breakthrough for nanotech, one company says it has found a way to combat age related diseases. If a company’s answer to a question...
ChromaDex TruNiagen
whoop

Latest articles